DCGI approves anti-Covid drug developed by DRDO for emergency use

The clinical trials of the therapy, drug 2-deoxy-D-glucose (2-DG), have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence, says govt

from Home Page https://ift.tt/3had2du
via IFTTT